Search results for "mesothelioma"

showing 10 items of 42 documents

Synthesis and antiproliferative activity of substituted 3[2-(1H-indol-3-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[3,2-b]pyridines, marine alkaloid nortopsenti…

2014

A large number of indolyl-4-azaindolyl thiazoles, nortopsentin analogues, were conveniently synthesized. The antiproliferative activity of the new derivatives was examined against four human tumor cell lines with different histologic origin. Seven derivatives consistently reduced the growth of the experimental models independently of TP53 gene status and exhibited the highest activity against the malignant peritoneal mesothelioma (STO) cell line. The most active compound of this series acts as a CDK1 inhibitor, and was found to cause cell cycle arrest at G 2 /M phase, to induce apoptosis by preventing the phosphorylation of survivin in Thr 34 and to increase the cytotoxic activity of paclit…

Cell cycle checkpointCDK1 InhibitorsAntiproliferative Activity CDK1 Inhibitors Diffuse Malignant Peritoneal Mesothelioma Nortopsentin Analogues SurvivinPyridinesStereochemistrySurvivinDiffuse Malignant Peritoneal MesotheliomaAntineoplastic AgentsApoptosisAntiproliferative Activity; CDK1 Inhibitors; Diffuse Malignant Peritoneal Mesothelioma; Nortopsentin Analogues; SurvivinBiochemistryCell LineAntiproliferative ActivityStructure-Activity Relationshipchemistry.chemical_compoundDrug DiscoverySurvivinHumansCytotoxic T cellProtein Kinase InhibitorsCell ProliferationPharmacologyCyclin-dependent kinase 1AlkaloidOrganic ChemistrySettore CHIM/08 - Chimica FarmaceuticaPaclitaxelchemistryCell cultureApoptosisNortopsentin AnaloguesMolecular Medicine
researchProduct

Development of a Tumor-Derived Extracellular Vesicle Engineering Protocol for Targeted Chemotherapeutic: A Novel Experimental Model using Malignant P…

2023

Extracellular VesicleTarget TherapyMalignant Pleural Mesothelioma
researchProduct

Laparoscopic excision of a benign peritoneal cystic mesothelioma

2009

Benign cystic peritoneal mesothelioma is a rare tumor and most commonly occurs in women in the reproductive age group. It is very rare in women of postmenopausal age. We present a rare case of a postmenopausal woman with benign peritoneal cystic mesothelioma removed at laparoscopy.

Laparoscopic surgerymedicine.medical_specialtyPeritoneal cystic mesotheliomamedicine.medical_treatmentReproductive ageLaparoscopic surgeryRare caseBenign peritoneal cystic mesothelioma; Laparoscopic surgerymedicineLaparoscopyneoplasmsmedicine.diagnostic_testbusiness.industryGeneral surgeryObstetrics and GynecologyMesothelioma CysticGeneral MedicineMiddle AgedLaparoscopic excisionmedicine.diseaseSettore MED/40 - Ginecologia E Ostetriciarespiratory tract diseasesSurgeryRare tumorPeritoneal mesotheliomaFemaleLaparoscopybusinessPeritoneal NeoplasmBenign peritoneal cystic mesotheliomaHuman
researchProduct

Pleural epithelioid angiosarcoma with lymphatic differentiation arisen after radiometabolic therapy for thyroid carcinoma: immunohistochemical findin…

2017

Abstract Background Pleural angiosarcoma is a rare tumor that causes diffuse pleural thickening and effusion, mimicking mesothelioma. Immunohistochemistry is needed to highlight endothelial differentiation. We describe the first case of pleural angiosarcoma with lymphatic differentiation following radiometabolic therapy for thyroid carcinoma. Case presentation A 50-year-old man showed diffuse pleural thickening and effusion. Nine years earlier, he underwent thyroidectomy and radiometabolic therapy for thyroid carcinoma with lymph node metastases. Histologically, the tumor consisted of a solid proliferation of atypical epithelioid cells and anastomosed vascular spaces, lacking of red blood c…

Male0301 basic medicinePathologymedicine.medical_specialtyNeoplasms Radiation-InducedHistologyPleural NeoplasmsHemangiosarcomaReviewRadiometabolic therapyPathology and Forensic MedicineIodine RadioisotopeIodine RadioisotopesThyroid carcinoma03 medical and health sciences0302 clinical medicinelcsh:PathologymedicineHumansAngiosarcomaThyroid NeoplasmsMesotheliomaPleural NeoplasmPleural angiosarcomaPleural NeoplasmLymph nodebusiness.industryThyroid CarcinomaGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistryCarcinoma Papillary030104 developmental biologymedicine.anatomical_structureHemangiosarcomaLymphatic systemThyroid Cancer Papillary030220 oncology & carcinogenesisbusinessEpithelioid celllcsh:RB1-214HumanDiagnostic Pathology
researchProduct

Benign multicystic mesothelioma: A case report of recurrent disease in a young adult with familiarity for renal cell carcinoma

2019

Benign multi-cystic peritoneal mesothelioma (BMCM) is a very rare disease (about 150 cases observed). The aetiology is currently little-known, and the data collected, without having achieved conclusive re sults, identify two possible causes: neoplastic and reactive inflammatory. This case report refers to a recidivism of BCMC in a patient whose brother, few months before, underwent a left nephrectomy and right renal Radio Frequency Termo Ablation (RFTA) for bilateral papillary renal cell carcinoma. For the recurring trend, the onset in a male young patient without chronic inflammatory diseases evidence, the presence of a first degree relative with a rare carcinoma we supposed a neoplastic a…

MaleHumansMesothelioma CysticMiddle AgedNeoplasm Recurrence Localbenign multcystic mesotheliom renal cells kideny tumor familiarity oncologyCarcinoma Renal CellKidney NeoplasmsPeritoneal Neoplasms
researchProduct

Asbestos: use, bans and disease burden in Europe

2014

To analyse national data on asbestos use and related diseases in the European Region of the World Health Organization (WHO).For each of the 53 countries, per capita asbestos use (kg/capita/year) and age-adjusted mortality rates (deaths/million persons/year) due to mesothelioma and asbestosis were calculated using the databases of the United States Geological Survey and WHO, respectively. Countries were further categorized by ban status: early-ban (ban adopted by 2000, n = 17), late-ban (ban adopted 2001-2013, n = 17), and no-ban (n = 19).Between 1920-2012, the highest per capita asbestos use was found in the no-ban group. After 2000, early-ban and late-ban groups reduced their asbestos use …

MaleMesotheliomaLung NeoplasmsDatabases FactualAsbestosismedicine.disease_causeWorld Health OrganizationAsbestosWorld healthEnvironmental healthmedicinePer capitaHumansMesotheliomaDisease burdenNational datahealth care economics and organizationsbusiness.industryMortality rateResearchPublic Health Environmental and Occupational HealthAsbestosmedicine.diseaseEuropeAsbestosisFemalebusinessBulletin of the World Health Organization
researchProduct

Diffuse malignant biphasic peritoneal mesothelioma with cystic areas

2016

We report a case of peritoneal biphasic mesothelioma with cystic areas in a patient with professional exposure to asbestos. It showed focal epithelial glandular and papillary proliferations, also presenting fluid filled cysts, whose wall consisted of a proliferation of spindle cells. Atypia and mitoses were very scanty. EMA, vimentin, CK5/6, D2-40, calretinin and P53 were positive and desmin was negative in both epithelial and spindle areas, including the ones surrounding the cystic spaces. These findings gave an essential aid in the differential diagnosis with a benign cystic mesothelioma and with a cystic epithelial mesothelioma with secondary pseudosarcomatous myofibroblastic proliferati…

MaleMesotheliomaLung NeoplasmsMesothelioma MalignantAscitesAsbestosMesothelioma CysticPemetrexedSettore MED/08 - Anatomia PatologicaAppendicitisCystic Mesothelioma Immunohistochemistry Malignant Mesothelioma Peritoneal Diseases Mesothelial Neoplasms.Diagnosis DifferentialSettore MED/18 - Chirurgia GeneraleCrohn DiseaseOccupational ExposureAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumorHumansCisplatinDiagnostic ErrorsPeritoneal NeoplasmsAged
researchProduct

Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas. An immunohistochemical study using monoclonal antibody AE1…

1989

In previous biochemical analyses, keratin 5 (Mr 58,000) has been detected in most mesotheliomas with epithelial component but not in pulmonary adenocarcinomas (Blobel et al., Am J Pathol 121: 235-247, 1985). In the present study, we have characterized a monoclonal antibody, AE14, as being selectively specific for keratin 5 (apart from the reactivity with certain hair proteins) as shown by immunoblotting of gel-electrophoretically separated proteins from various tissues. Immunohistochemical screening of a variety of normal human tissues, using immunoperoxidase microscopy on cryostat sections, revealed the binding of this antibody to the basal, immature cells of stratified squamous epithelia,…

MaleMesotheliomaPathologymedicine.medical_specialtyImmunoblottingAdenocarcinomaEpitheliumDiagnosis DifferentialImmunoenzyme TechniquesKeratinmedicineHumanschemistry.chemical_classificationImmunoperoxidasebiologyMyoepithelial cellAntibodies Monoclonalmedicine.diseaseImmunohistochemistrySquamous metaplasiaStainingKeratin 5chemistrybiology.proteinImmunohistochemistryKeratinsFemaleAntibodyHairVirchows Archiv. B, Cell pathology including molecular pathology
researchProduct

Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: The outcome of incomplete resections

2013

The type of surgery (radical pleurectomy (RP) vs. extrapleural pneumonectomy (EPP)) remains controversial for malignant pleural mesothelioma (MPM). Macroscopic complete resection (MCR) is a key prognostic factor. It is unclear, if patients undergoing incomplete RP within a standardized multimodality treatment protocols have any advantage in terms of survival and if EPP could theoretically have avoided incomplete resections (R2).Eighty-eight patients underwent RP followed by chemoradiation from 2002 to 2011 within a prospective multimodality treatment study at a single institution. MCR were compared to R2 within this patient cohort retrospectively. EPP eligibility was assessed retrospectivel…

MaleMesotheliomaPulmonary and Respiratory MedicineExtrapleural PneumonectomyCancer Researchmedicine.medical_specialtyPrognostic factorLung NeoplasmsPleural NeoplasmsKaplan-Meier EstimateDisease-Free SurvivalmedicineHumansProspective StudiesStage (cooking)PneumonectomyAgedRetrospective StudiesProportional hazards modelPleural mesotheliomabusiness.industryMultimodality TreatmentMesothelioma MalignantChemoradiotherapyThoracic Surgical ProceduresCombined Modality TherapySurvival AnalysisSurgeryTreatment OutcomeOncologyCohortFemalebusinessPleurectomyhormones hormone substitutes and hormone antagonistsLung Cancer
researchProduct

Prospective Study on Functional Results After Lung-Sparing Radical Pleurectomy in the Management of Malignant Pleural Mesothelioma

2012

Introduction:Malignant pleural mesothelioma (MPM) can reduce lung function by entrapping lung parenchyma via a rind of tumor with or without concurrent effusion. Radical pleurectomy (RP) allows expansion of the trapped lung. The purpose of this study was to investigate changes in pulmonary function and lung perfusion in patients undergoing RP.Methods:In a prospective, nonrandomized study, all patients with histologically proven MPM were evaluated from January to December 2010 for trimodality therapy including RP as surgical procedure. Pulmonary-function tests and perfusion scans were obtained before and 2 months after RP. Primary end points were pulmonary function (forced vital capacity [FV…

MaleMesotheliomaPulmonary and Respiratory MedicineVital capacitymedicine.medical_specialtyPulmonary functionPleural Neoplasmsmedicine.medical_treatmentVital CapacityUrologyPulmonary function testingFEV1/FVC ratiomedicineHumansProspective StudiesMesotheliomaDecorticationProspective cohort studyPleurectomyAgedLungbusiness.industryrespiratory systemDecorticationPrognosismedicine.diseaseRespiratory Function Testsrespiratory tract diseasesSurgeryPerfusionmedicine.anatomical_structureOncologyEffusionFemalebusinessJournal of Thoracic Oncology
researchProduct